-
All Resources
(choose a category)
-
All Resources
-
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
-
Resource Type
- NICE Guidance
- Programme
- Year
- prev
- Page 10 of 1
1 results found filtered by 2011 Remove 2011 Filter 2012 Remove 2012 Filter NICE Guidance Remove NICE Guidance Filter Blood and immune system Remove Blood and immune system Filter Clear Search
-
Appraisal Guidance No 84 - The use of drotrecogin alfa (activated) for severe sepsis
- Published
- 25 October 2011
- Cycle of Improvement
- Evidence